Evidence map›Paper›PMID 10564261›Full record

ArticleMolecular biology of the cell1999

Chimeric cytokine receptor can transduce expansion signals in interleukin 6 receptor alpha (IL-6Ralpha)-, IL-11Ralpha-, and gp130-low to -negative primitive hematopoietic progenitors.

M Takagi, T Nakamura, T Sawada, A Kaneko, M Nozaki-Ukai, T Nakahata, T Yokota, T Heike

Open access · greenAbstract read
In one paragraph

Article in Molecular biology of the cell, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Arming CAR-T cells with cytokines and more: Innovations in the fourth-generation CAR-T development.Molecular therapy : the journal of the American Society of Gene Therapy · 2023
    Review
  2. STAT3-Activating Cytokines: A Therapeutic Opportunity for Inflammatory Bowel Disease?Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research · 2015
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

M TakagiDepartment of Stem Cell Regulation, Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan.
T Nakamura
T Sawada
A Kaneko
M Nozaki-Ukai
T Nakahata
T Yokota
T Heike
The University of Tokyo · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We generated transgenic mice expressing chimeric receptors, which comprise extracellular domains of the human granulocyte-macrophage colony-stimulating factor (hGM-CSF) receptor and transmembrane and cytoplasmic domains of the mouse leukemia inhibitory factor receptor. In suspension cultures of lineage-negative (Lin(-)), 5-fluorouracil-resistant bone marrow cells of the transgenic mice, a combination of hGM-CSF and stem cell factor (SCF) induced exponential expansions of mixed colony-forming unit. The combination of hGM-CSF and SCF was effective on enriched, Lin(-)Sca-1(+)c-kit(+) progenitors and increased either mixed colony-forming unit or cobblestone area-forming cells. In case of stimulation with hGM-CSF and SCF, interleukin-6 (IL-6) and SCF, or IL-11 and SCF, the most efficient expansion was achieved with hGM-CSF and SCF. When Lin(-)Sca-1(+)c-kit(+)CD34(-) further enriched progenitors were clone sorted and individually incubated in the presence of SCF, hGM-CSF stimulated a larger number of cells than did IL-6, IL-6 and soluble IL-6 receptor (IL-6R), or IL-11. These data suggest the presence of IL-6Ralpha-, IL-11Ralpha-, and gp130-low to -negative primitive hematopoietic progenitors. Such primitive progenitors are equipped with signal transduction molecules and can expand when these chimeric receptors are genetically introduced into the cells and stimulated with hGM-CSF in the presence of SCF.

Indexed as

Growth InhibitorsInterleukin-6LymphokinesAnimalsAntigens, CDClone CellsColony-Forming Units AssayCytokine Receptor gp130Flow CytometryFluorouracilGranulocyte-Macrophage Colony-Stimulating FactorHematopoietic Stem CellsHumansInterleukin-11 Receptor alpha SubunitLeukemia Inhibitory FactorLeukemia Inhibitory Factor Receptor alpha SubunitAntigens, CDCytokine Receptor gp130FluorouracilGranulocyte-Macrophage Colony-Stimulating FactorGrowth InhibitorsIl11ra1 protein, mouseIl11ra2 protein, mouseIL11RA protein, humanIL6ST protein, humanIl6st protein, mouseInterleukin-11 Receptor alpha SubunitInterleukin-6Leukemia Inhibitory FactorLeukemia Inhibitory Factor Receptor alpha SubunitLIF protein, humanLif protein, mouseLIFR protein, humanLifr protein, mouseLymphokinesMembrane GlycoproteinsReceptors, CytokineReceptors, Granulocyte-Macrophage Colony-Stimulating FactorReceptors, InterleukinReceptors, Interleukin-11Receptors, Interleukin-6Receptors, OSM-LIFRecombinant Fusion Proteins

Identifiers

PMID10564261
PMCPMC25652
OpenAlexW2166933390

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.